Journal of Asthma and Allergy

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Targeted Personalized Biologic Therapies: Changing the Game in Asthma Treatment” in the Journal of Asthma and Allergy.

This Collection, edited by the Editor-In-Chief Dr. Amrita Dosanjh, is part of the new Game Changer series of Article Collections, focusing on breakthrough therapies, drugs, and technologies that have significantly altered the standard of care, leading to game-changing improvements in patient outcomes.

Asthma is a chronic inflammatory lung condition that results in airway obstruction and difficulty breathing. Left untreated, severe asthma flares can lead to hospitalization and even death. Typical front-line treatments of asthma include corticosteroids (which cause immunosuppression with long-term use) and bronchodilators (such as albuterol inhalers). While biologic therapy is relatively new in asthma treatment, Global Initiative For Asthma (GINA) guidelines include biologics as therapeutic options. There are several biologics currently available and in development for the treatment of asthma.

While the call is open to receive manuscripts across the broad spectrum of asthma-modulating biologics, the Editors are particularly interested in manuscripts relating to the following areas:

• Signaling pathways and cellular targets
• Novel mechanisms of action of new candidate biologics
• Anti IL-4 and IL-13 combination biologics and monoclonal antibodies
• Treatment and dosing strategies based on asthma typing
• Biologic switching and combination therapy
• Long-term efficacy and safety studies

Submitting authors are eligible for a 20% discount on the Article Publishing charge by applying the following code at the point of submission SRNMA. If you have any queries regarding the Article Collection or would like to discuss a submission, then please email the Commissioning Editor Ashley Ambros at [email protected].

Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.

All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript as it will be rejected if it does not fall within the scope of the journal.

Please submit your manuscript on our website. The deadline for submitting manuscripts is 1 April 2026.

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Advances in Rhinology and Allergy: From Disease Mechanisms to Treatment Innovations” in the Journal of Asthma and Allergy.

Rhinologic and allergic disorders, such as acute/chronic rhinosinusitis, nasal polyposis, allergic/non-allergic rhinitis etc., frequently cause physical and mental illness. Despite the rapid progress of medicine, some rhinologic disorders remain complex and have a significant impact on the global economy in the modern era.

Early detection and proper management of the rhinologic disorders based on disease mechanisms deserve further attention. Advances in disease mechanisms and treatment innovations would provide practical information about precise medicine and prediction in response to medical or surgical therapy and are therefore pivotal.

This Article Collection aims to highlight recent advances in the disease mechanisms and treatment innovations in rhinology and allergy. Rapid progress in basic science, translational medicine, and biomedical technology has significantly improved our understanding of the pathophysiology underlying rhinologic and allergic disorders. We invite authors to submit original research articles, reviews, and clinical studies that investigate the molecular and cellular mechanisms of diseases in rhinology and allergy, as well as innovative diagnostic and therapeutic methods.

Keywords

• Chronic rhinosinusitis
• Rhinitis
• Allergy
• Nasal surgery
• Pathophysiology

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this Collection will not be handling the manuscripts (unless they are an Editorial Board member).

Please review the journal scope and author submission instructions prior to submitting a manuscript.
The deadline for submitting manuscripts is 31 December 2026.

Please submit your manuscript on our website, quoting the promo code 4F6E6 to indicate the paper is intended for consideration in the Article Collection.

Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

Please be sure to select the appropriate Article Collection from the drop-down menu in the submission system.

Guest Advisor

Professor Chien-Chia Huang, Division of Rhinology, Department of Otolaryngology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan

[email protected]

Prof. Chien-Chia Huang is associate professor of Division of Rhinology, Department of Otolaryngology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. He also serves as director of the Division of Paediatric Otolaryngology. He obtained his degree in Medicine at the University of Chang Gung University (Taiwan). His PhD was issued by the University of Chang Gung University. His main research interests are the rhinologic and allergic diseases, including chronic rhinosinusitis, rhinitis, and obstructive sleep apnea.

 

 

 

 

 

View all papers in this article collection